These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3313061)

  • 1. Mutations of the Kirsten-ras proto-oncogene in human preleukaemia.
    Liu E; Hjelle B; Morgan R; Hecht F; Bishop JM
    Nature; 1987 Nov 12-18; 330(6144):186-8. PubMed ID: 3313061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A point mutation at codon 13 of the N-ras oncogene in myelodysplastic syndrome.
    Hirai H; Kobayashi Y; Mano H; Hagiwara K; Maru Y; Omine M; Mizoguchi H; Nishida J; Takaku F
    Nature; 1987 Jun 4-10; 327(6121):430-2. PubMed ID: 3295562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Point mutation of the ras protooncogenes and chromosome aberrations in acute nonlymphocytic leukemia and preleukemia related to therapy with alkylating agents.
    Pedersen-Bjergaard J; Janssen WG; Lyons J; Philip P; Bartram CR
    Cancer Res; 1988 Apr; 48(7):1812-7. PubMed ID: 3280121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Transforming gene in the preleukemic state].
    Takaku F; Hirai H; Nishida J
    Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 2):2170-5. PubMed ID: 3606144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic lesions in preleukemia.
    Padua RA
    Acta Haematol Pol; 1993; 24(3):213-9. PubMed ID: 8249536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular genetics of malignant insulinoma.
    Pavelic K; Hrascan R; Kapitanovic S; Vranes Z; Cabrijan T; Spaventi S; Korsic M; Krizanac S; Li YQ; Stambrook P; Gluckman JL; Pavelic ZP
    Anticancer Res; 1996; 16(4A):1707-17. PubMed ID: 8712689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycine-cysteine substitution at codon 13 of the N-ras proto-oncogene in a human T cell non-Hodgkin's lymphoma.
    Wodnar-Filipowicz A; Senn HP; Jiricny J; Signer E; Moroni C
    Oncogene; 1987; 1(4):457-61. PubMed ID: 3330790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic lesions in preleukemia.
    Carter G; Ridge S; Padua RA
    Crit Rev Oncog; 1992; 3(4):339-64. PubMed ID: 1420444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatic deletions and mutations of c-Ha-ras gene in human cervical cancers.
    Riou G; Barrois M; Sheng ZM; Duvillard P; Lhomme C
    Oncogene; 1988 Sep; 3(3):329-33. PubMed ID: 3060795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukaemia-related gene expression in bone marrow cells from patients with the preleukaemic disorder Shwachman-Diamond syndrome.
    Rujkijyanont P; Beyene J; Wei K; Khan F; Dror Y
    Br J Haematol; 2007 Jun; 137(6):537-44. PubMed ID: 17539775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of stable CD4+ and CD8+ T cell lines from patients immunized with ras oncogene-derived peptides reflecting codon 12 mutations.
    Abrams SI; Khleif SN; Bergmann-Leitner ES; Kantor JA; Chung Y; Hamilton JM; Schlom J
    Cell Immunol; 1997 Dec; 182(2):137-51. PubMed ID: 9514698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in ras oncogenes: rare events in ultraviolet B radiation-induced mouse skin tumorigenesis.
    Khan SG; Mohan RR; Katiyar SK; Wood GS; Bickers DR; Mukhtar H; Agarwal R
    Mol Carcinog; 1996 Feb; 15(2):96-103. PubMed ID: 8599584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physician Education: Myelodysplastic Syndrome.
    Yoshida Y
    Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization.
    Hruban RH; van Mansfeld AD; Offerhaus GJ; van Weering DH; Allison DC; Goodman SN; Kensler TW; Bose KK; Cameron JL; Bos JL
    Am J Pathol; 1993 Aug; 143(2):545-54. PubMed ID: 8342602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of oncogenes in human oral cancer cells: a novel codon 13 mutation of c-H-ras-1 and concurrent amplifications of c-erbB-1 and c-myc.
    Tadokoro K; Ueda M; Ohshima T; Fujita K; Rikimaru K; Takahashi N; Enomoto S; Tsuchida N
    Oncogene; 1989 Apr; 4(4):499-505. PubMed ID: 2654810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung.
    Vachtenheim J; Horáková I; Novotná H; Opáalka P; Roubková H
    Clin Cancer Res; 1995 Mar; 1(3):359-65. PubMed ID: 9815992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneous patterns of CEBPalpha mutation status in the progression of myelodysplastic syndrome and chronic myelomonocytic leukemia to acute myelogenous leukemia.
    Shih LY; Huang CF; Lin TL; Wu JH; Wang PN; Dunn P; Kuo MC; Tang TC
    Clin Cancer Res; 2005 Mar; 11(5):1821-6. PubMed ID: 15756005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of carcinogenesis: the role of oncogenes, transcriptional enhancers and growth factors.
    Spandidos DA
    Anticancer Res; 1985; 5(5):485-98. PubMed ID: 3904595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ras gene activation in a minor proportion of the blast population in acute myeloid leukemia.
    Toksoz D; Farr CJ; Marshall CJ
    Oncogene; 1987; 1(4):409-13. PubMed ID: 3330783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of normal and mutant ras proteins in human acute leukemia.
    Shen WP; Aldrich TH; Venta-Perez G; Franza BR; Furth ME
    Oncogene; 1987 May; 1(2):157-65. PubMed ID: 3325880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.